Skip to content

The effect of Melissa on stress and hemodynamic parameters

The effect of aromatherapy with Melissa Officinalis essene on Stress and Hemodynamic parameters of patients with acute coronary syndrome at Emergency unit

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150919024080N14
Enrollment
72
Registered
2019-12-07
Start date
2019-10-23
Completion date
Unknown
Last updated
2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Acute coronary syndrom. Condition 2: Stress. Condition 3: Aromatherapy. Condition 4: Mean atrial pressure and Heart rate. Non-ST elevation (NSTEMI) myocardial infarction Acute stress reaction

Interventions

Intervention 1: Intervention group: Melissa officinalis essence 80%, one drop, two times and 90 minutes away?For 10 minutes at a time? Inhaler with oxygen mask? Adonis Pharmaceutical Company. Interven

Sponsors

Khoram-Abad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: Definitive diagnosis of acute coronary syndrome by a specialist based on evidence based electrocardiogram and clinical signs and troponin index No respiratory disease such as asthma and COPD and allergies or allergies to plants Entering the emergency department without cardiac arrest Vigilance and Awareness of place, time and person No history of head trauma and seizure No history of confirmed mental illness No opium and alcohol addiction No history of PTSD in during the last six months No history of using other complementary therapies for at least one month before intervention No disruption of sense of smell Mean arterial blood pressure more than 90 and heart rate more than 60 Patients with chest pain severity of 3 and more based on visual analogue scale (VAS) Age over 35 and under 65 years

Exclusion criteria

Exclusion criteria: Patients Candidate for primary PCI Patient's unwillingness to continue participation Unstable hemodynamic (20% change compared to time of start intervention) Incidence of arrhythmias and allergic and respiratory problems during intervention Transfer patients from the emergency department to the intensive care unit in less than 3 hours Patient connection to mechanical ventilation

Design outcomes

Primary

MeasureTime frame
Stress score in DASS-21 questionnaire. Timepoint: Before intervention, 5 and 15 minutes after the end of aromatherapy on two occasions of aromatherapy. Method of measurement: DASS-21 Stress Questionnaire.;Mean Atrial Pressure. Timepoint: Before intervention, 5 and 15 minutes after the end of aromatherapy on two occasions of aromatherapy. Method of measurement: Cardiac Monitoring machine.;Heart rate. Timepoint: Before intervention, 5 and 15 minutes after the end of aromatherapy on two occasions of aromatherapy. Method of measurement: Cardiac Monitoring machine.;Threat perception score. Timepoint: Before and the end of intervention. Method of measurement: Threat Perception Questionnaire.

Secondary

MeasureTime frame
??? ?? ??????pain. Timepoint: Before the intervention, 5 and 15 minutes after the intervention in two aromatherapy treatments. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtefe Veiskaramian

Khoram-Abad University of Medical Sciences

a.veiskaramian67@gmail.com+98 916 661 8071

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026